BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19346963)

  • 1. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma.
    Reichardt W; Juettner E; Uhl M; Elverfeldt DV; Kontny U
    Invest Radiol; 2009 May; 44(5):298-303. PubMed ID: 19346963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
    Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
    Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas.
    Dudeck O; Zeile M; Pink D; Pech M; Tunn PU; Reichardt P; Ludwig WD; Hamm B
    J Magn Reson Imaging; 2008 May; 27(5):1109-13. PubMed ID: 18425832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
    Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
    Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging in patients with acute brain ischemia at 3 T: current possibilities and future perspectives comparing conventional echoplanar diffusion-weighted imaging and fast spin echo diffusion-weighted imaging sequences using BLADE (PROPELLER).
    Fries P; Runge VM; Kirchin MA; Stemmer A; Naul LG; Wiliams KD; Reith W; Bücker A; Schneider G
    Invest Radiol; 2009 Jun; 44(6):351-9. PubMed ID: 19363447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudonormalization of diffusion weighted images: magnetic resonance imaging in an animal model (C6-glioma)].
    Hartmann M; Junkers R; Herold-Mende C; Ahmadi R; Heiland S
    Rofo; 2005 Jan; 177(1):114-8. PubMed ID: 15657829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver.
    Youn BJ; Chung JW; Son KR; Kim HC; Jae HJ; Lee JM; Song IC; Kim IO; Park JH
    Acad Radiol; 2008 May; 15(5):593-600. PubMed ID: 18423316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.
    Sancéau J; Poupon MF; Delattre O; Sastre-Garau X; Wietzerbin J
    Oncogene; 2002 Oct; 21(50):7700-9. PubMed ID: 12400012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
    Lang P; Vahlensieck M; Matthay KK; Johnston JO; Rosenau W; Gooding CA; Genant HK
    Med Pediatr Oncol; 1996 May; 26(5):329-33. PubMed ID: 8614366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MRI of hepatic tumor in rats: comparison between in vivo and postmortem imaging acquisitions.
    Sun X; Wang H; Chen F; De Keyzer F; Yu J; Jiang Y; Feng Y; Li J; Marchal G; Ni Y
    J Magn Reson Imaging; 2009 Mar; 29(3):621-8. PubMed ID: 19243058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
    Chenevert TL; McKeever PE; Ross BD
    Clin Cancer Res; 1997 Sep; 3(9):1457-66. PubMed ID: 9815831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
    Vossen JA; Kamel IR; Buijs M; Liapi E; Georgiades CS; Hong K; Geschwind JF
    J Comput Assist Tomogr; 2008; 32(3):347-52. PubMed ID: 18520535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potentialities of MR tomography in monitoring the therapy of malignant bone tumors].
    Just M; Gutjahr P; Higer HP; Störkel S; Rudigier J; Ritter G; Pfannenstiel P
    Rofo; 1987 Oct; 147(4):413-9. PubMed ID: 2825264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.
    Thoeny HC; De Keyzer F; Chen F; Ni Y; Landuyt W; Verbeken EK; Bosmans H; Marchal G; Hermans R
    Radiology; 2005 Mar; 234(3):756-64. PubMed ID: 15734932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
    Garg V; Zhang W; Gidwani P; Kim M; Kolb EA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
    Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
    J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of rodent liver tumor with combretastatin a4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology.
    Wang H; Sun X; Chen F; De Keyzer F; Yu J; Landuyt W; Vandecaveye V; Peeters R; Bosmans H; Hermans R; Marchal G; Ni Y
    Invest Radiol; 2009 Jan; 44(1):44-53. PubMed ID: 19034028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.